Status:
COMPLETED
Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema
Lead Sponsor:
Cwm Taf University Health Board (NHS)
Collaborating Sponsors:
University of South Wales
Conditions:
Lymphoedema of Leg
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression (IPC) represents an innovative tr...
Detailed Description
The primary aim of this research is to evaluate the effectiveness of intermittent pneumatic compression (IPC) as a treatment for lower limb lymphoedema as a whole, and to compare the effectiveness of ...
Eligibility Criteria
Inclusion
- Age 18 or over,
- Able to provide written consent,
- Confirmed diagnosis of lower limb ISL stage II or III.
Exclusion
- • Unable to provide written consent
- Severe congestive heart failure
- Severe skin problems, lower limb ulcers or wounds.
- Presence of cognitive impairment (permanent or intermittent) which would prevent patients from using the IPC device safely or adhering to instructions/study protocol.
- Non-pitting chronic lymphoedema.
- Known or suspected deep vein thrombosis.
- Pulmonary embolism.
- Thrombophlebitis.
- Acute inflammation of the skin (erysipelas, cellulitis).
- Uncontrolled/severe cardiac failure.
- Pulmonary oedema.
- Ischaemic vascular disease.
- Active cancer diagnosis.
- Active metastatic diseases affecting the oedematous region.
- Oedema at the root of the extremity or truncal oedema.
- Severe peripheral neuropathy.
Key Trial Info
Start Date :
July 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03856281
Start Date
July 10 2018
End Date
December 10 2019
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dewi Sant Hospital
Pontypridd, United Kingdom, CF37 1LB